These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26383996)

  • 1. Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT).
    Ying GS; Maguire MG; Daniel E; Ferris FL; Jaffe GJ; Grunwald JE; Toth CA; Huang J; Martin DF;
    Ophthalmology; 2015 Dec; 122(12):2523-31.e1. PubMed ID: 26383996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
    Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
    Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
    Ying GS; Huang J; Maguire MG; Jaffe GJ; Grunwald JE; Toth C; Daniel E; Klein M; Pieramici D; Wells J; Martin DF;
    Ophthalmology; 2013 Jan; 120(1):122-9. PubMed ID: 23047002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
    ; Maguire MG; Martin DF; Ying GS; Jaffe GJ; Daniel E; Grunwald JE; Toth CA; Ferris FL; Fine SL
    Ophthalmology; 2016 Aug; 123(8):1751-1761. PubMed ID: 27156698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
    Jaffe GJ; Martin DF; Toth CA; Daniel E; Maguire MG; Ying GS; Grunwald JE; Huang J;
    Ophthalmology; 2013 Sep; 120(9):1860-70. PubMed ID: 23642377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
    Daniel E; Shaffer J; Ying GS; Grunwald JE; Martin DF; Jaffe GJ; Maguire MG;
    Ophthalmology; 2016 Mar; 123(3):609-16. PubMed ID: 26681392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).
    Altaweel MM; Daniel E; Martin DF; Mittra RA; Grunwald JE; Lai MM; Melamud A; Morse LS; Huang J; Ferris FL; Fine SL; Maguire MG; ;
    Ophthalmology; 2015 Feb; 122(2):391-398.e5. PubMed ID: 25307130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Shah N; Maguire MG; Martin DF; Shaffer J; Ying GS; Grunwald JE; Toth CA; Jaffe GJ; Daniel E;
    Ophthalmology; 2016 Apr; 123(4):858-64. PubMed ID: 26778329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Daniel E; Ying GS; Kim BJ; Toth CA; Ferris F; Martin DF; Grunwald JE; Jaffe GJ; Dunaief JL; Pan W; Maguire MG;
    Ophthalmology; 2019 May; 126(5):743-751. PubMed ID: 30476517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Eyes With Good Visual Acuity at 5 Years After Initiation of Treatment for Age-Related Macular Degeneration but Not Receiving Treatment From Years 3 to 5: Post Hoc Analysis of the CATT Randomized Clinical Trial.
    Scoles D; Ying GS; Pan W; Hua P; Grunwald JE; Daniel E; Jaffe GJ; Toth CA; Martin DF; Maguire MG;
    JAMA Ophthalmol; 2020 Mar; 138(3):276-284. PubMed ID: 31999297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
    Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
    Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Core JQ; Pistilli M; Daniel E; Grunwald JE; Toth CA; Jaffe GJ; Hua P; Martin DF; Ying GS; Maguire MG;
    Ophthalmol Retina; 2021 Oct; 5(10):962-974. PubMed ID: 34126249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).
    Hagstrom SA; Ying GS; Pauer GJT; Sturgill-Short GM; Huang J; Callanan DG; Kim IK; Klein ML; Maguire MG; Martin DF;
    Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT).
    Lee JY; Folgar FA; Maguire MG; Ying GS; Toth CA; Martin DF; Jaffe GJ;
    Ophthalmology; 2014 Dec; 121(12):2423-31. PubMed ID: 25064723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Ciulla TA; Ying GS; Maguire MG; Martin DF; Jaffe GJ; Grunwald JE; Daniel E; Toth CA;
    Ophthalmology; 2015 Jun; 122(6):1203-11. PubMed ID: 25824327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
    Cochrane Database Syst Rev; 2014 Aug; 8(8):CD005139. PubMed ID: 25170575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of scar in the comparison of age-related macular degeneration treatments trials.
    Daniel E; Toth CA; Grunwald JE; Jaffe GJ; Martin DF; Fine SL; Huang J; Ying GS; Hagstrom SA; Winter K; Maguire MG;
    Ophthalmology; 2014 Mar; 121(3):656-66. PubMed ID: 24314839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Daniel E; Pan W; Ying GS; Kim BJ; Grunwald JE; Ferris FL; Jaffe GJ; Toth CA; Martin DF; Fine SL; Maguire MG;
    Ophthalmology; 2018 Jul; 125(7):1037-1046. PubMed ID: 29454660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.